Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Molecular Diagnostics : JMD|August 25, 2019
A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability-High Cases in 67,000 Patient SamplesSally E Trabucco, Kyle Gowen, Sophia L Maund, et al.
Cancer Immunology Research|April 24, 2020
Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate CancerMarie-Claire Wagle, Joseph Castillo, Shrividhya Srinivasan, et al.
Blood|July 10, 2014
PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogeneZhuyan Guo, Anlai Wang, Weidong Zhang, et al.
NPJ Precision Oncology|June 7, 2018
A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer typesMarie-Claire Wagle, Daniel Kirouac, Christiaan Klijn, et al.
The Journal of Biological Chemistry|September 5, 2013
Evaluation of cancer dependence and druggability of PRP4 kinase using cellular, biochemical, and structural approachesQiang Gao, Ingrid Mechin, Nayantara Kothari, et al.
Plos One|October 6, 2017
Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumorsMark Merchant, John Moffat, Gabriele Schaefer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2019
An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid TumorsRui Wang, Chan Gao, Megan Raymond, et al.
Plos One|January 26, 2018
Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumorsMark Merchant, John Moffat, Gabriele Schaefer, et al.
Cancer Research|June 12, 2019
CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional MechanismsJoseph Castillo, Esther Wu, Christopher Lowe, et al.
Molecular Cancer Research : MCR|March 12, 2015
Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network DeregulationTimothy R Wagenaar, Sonya Zabludoff, Sung-Min Ahn, et al.
Pageof 3